Artificial Pancreas Device Systems Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

The global artificial pancreas device systems market was valued at USD 784.57 Million in 2025, driven by increasing prevalence of diabetes across the globe. The market is expected to grow at a CAGR of 20.00% during the forecast period of 2026-2035, with the values likely to reach USD 4857.85 Million by 2035.

Q1 2026 Market Updates

Geopolitical Impact of Iran, US, and Israel War on the Artificial Pancreas Device Systems Market

United States: The Artificial Pancreas Device Systems Market, a key segment of the global economy, is experiencing a complex operating environment in Q1 2026 as a direct consequence of the US-Israel-Iran war. Diesel costs have risen approximately 40% from late February to mid-March 2026, directly inflating operating costs for all freight and logistics operations. Jet fuel costs have nearly doubled. Regional airspace closures across Iran, Iraq, Israel, Bahrain, Kuwait, Qatar, UAE, and Syria are forcing airlines to reroute, adding 1-2 hours and significant fuel costs. Global ocean freight costs are up 30% from rerouting and war-risk insurance surcharges. Air cargo costs have risen approximately 10% per week since the conflict began. FedEx and UPS have suspended Middle East services. Major carriers including Maersk and Hapag-Lloyd are routing vessels around the Cape of Good Hope, adding 3,500 nautical miles and approximately USD 1M per voyage. U.S. freight costs are rising: UPS and FedEx fuel surcharges now run 23-27% and 25.5% respectively, with USPS filing its first-ever 8% emergency fuel surcharge on March 25.

Iran: Iran's domestic Artificial Pancreas Device Systems sector has been effectively suspended by the conflict. US-Israeli strikes on industrial and civilian infrastructure across Tehran, Mashhad, Isfahan, and other major cities have disrupted all commercial activity. Power outages from attacks on electricity generation facilities have halted manufacturing operations, and the collapse of the commercial banking and logistics system has eliminated any residual trade flows. The broader humanitarian crisis, with over 1,900 casualties and 4,000+ civilian buildings damaged, has redirected the entire Iranian economy toward survival rather than production or consumption.

Israel: Israel's Artificial Pancreas Device Systems sector is experiencing near-term disruption from wartime conditions. Consumer spending on non-essential categories has declined as millions of Israelis regularly shelter from missile and drone alerts. Supply chain logistics are disrupted by regional airspace closures, elevated war-risk insurance premiums, and the suspension of major carrier services through the region. International business partnerships with Israeli companies have been temporarily suspended. Post-conflict reconstruction and recovery demand is expected to provide meaningful demand acceleration across affected market segments once operational conditions normalise.

Key Takeaways

Government

• Relevant transport authorities should implement emergency fuel cost support mechanisms for commercial freight operators, recognising that 40% diesel cost increases are threatening the viability of smaller carriers and creating inflationary pressure throughout supply chains.
• Aviation regulators should coordinate with carriers on emergency route optimisation protocols that minimise the operational impact of Middle Eastern airspace closures, reducing the fuel cost penalty for rerouted international services.
• Trade ministries should assess port and logistics capacity constraints from diverted shipping around the Cape of Good Hope, ensuring that alternative routing does not create bottlenecks at non-Gulf hub ports.

Market

• Diesel costs up approximately 40% and jet fuel costs nearly doubled are creating the most significant fuel inflation shock for the transport sector since the 2022 commodity cycle, with impacts that are expected to persist throughout the conflict.
• The suspension of Middle Eastern airspace and the Cape of Good Hope rerouting of container shipping are adding structural cost increases to global logistics chains that cannot be rapidly reversed even if a ceasefire is reached.
• Electric and alternative fuel transport solutions are receiving a powerful demand signal from the conflict's petroleum cost shock, accelerating fleet electrification planning across commercial transport operators globally.

Procurement

• Fleet operators and logistics companies should lock in fuel hedging arrangements at current diesel prices ahead of further escalation, and activate variable fuel surcharge mechanisms to protect margins during the conflict period.
• Procurement teams should build 60-day buffer inventory for critical transport consumables, maintenance parts, and equipment components, given that global freight costs are elevated and lead times extended by the Cape of Good Hope rerouting.
• Supply chain managers should review routing optimisation for all freight movements, assessing whether multi-modal and nearshoring strategies can reduce the fuel cost and logistics disruption exposure created by Gulf shipping route closures.

Key Market Insights

• Rising FDA approvals, such as Medtronic’s MiniMed™ 780G artificial pancreas (April 2023), are accelerating innovation and strengthening market growth during the forecast period.
• Technologically advanced automated insulin delivery systems, including Beta Bionics’ iLet bionic pancreas with FDA 510(k) clearance (May 2023), are transforming diabetes management and improving patient outcomes.
• North America is expected to dominate the market, supported by strong regulatory approvals, early adoption of advanced diabetes technologies, and a well-established healthcare infrastructure.

Market Size & Forecast

• Market Size in 2025: USD 784.57 Million
• Projected Market Size in 2035: USD 4857.85 Million
• CAGR from 2026 to 2035: 20.00%